TY  - JOUR
AU  - Zozaya, Néboa
AU  - Martínez-Galdeano, Lucía
AU  - Alcalá, Bleric
AU  - Armario-Hita, Jose Carlos
AU  - Carmona, Concepción
AU  - Carrascosa, Jose Manuel
AU  - Herranz, Pedro
AU  - Lamas, María Jesús
AU  - Trapero-Bertran, Marta
AU  - Hidalgo-Vega, Álvaro
PY  - 2018
DO  - 10.1007/s40259-018-0284-3
UR  - http://hdl.handle.net/10668/12515
T2  - BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
AB  - Multi-criteria decision analysis (MCDA) is a tool that systematically considers multiple factors relevant to health decision-making. The aim of this study was to use an MCDA to assess the value of dupilumab for severe atopic dermatitis compared with...
LA  - en
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Chronic Disease
KW  - Clinical Decision-Making
KW  - Decision Support Techniques
KW  - Dermatitis, Atopic
KW  - Humans
KW  - Psoriasis
KW  - Severity of Illness Index
KW  - Treatment Outcome
TI  - Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis.
TY  - research article
VL  - 32
ER  -